Tate & Lyle PLC

Public consensus   -   Last updated 20/12/24

Reporting currency: GBP
Reporting unit: Millions
 
NO. OF
FORECASTS
FY25 - Continuing
CONSENSUS
20/12/24
FY25 - Continuing
MEDIAN
FY25 - Continuing
MIN
FY25 - Continuing
MAX
Volume change (%)
Volume change - Food & Beverage Solutions
Total Food & Beverage Solutions
6
4
5
(5)
6
Volume change - SPLENDA® Sucralose
SPLENDA® Sucralose
6
5
5
5
6
Volume change - Primary Products Europe
Primary Products Europe
6
(6)
(7)
(25)
10
Group Income Statement (£m)
Revenue - Food & Beverage Solutions
Food & Beverage Solutions
6
1,283
1,278
1,256
1,327
Revenue - Sucralose
Sucralose
6
175
175
172
177
Revenue - Primary Products Europe
Primary Products Europe
6
89
91
80
94
Revenue - Continuing Operations
6
1,787
1,787
1,716
1,886
Adjusted EBITDA
Food & Beverage Solutions
6
293
291
288
303
Sucralose
6
53
54
51
56
Primary Products Europe
6
(4)
(4)
(6)
(3)
Adjusted EBITDA - Continuing Operations
6
387
387
375
398
Less: Depreciation and adjusted amortisation
6
(95)
(96)
(104)
(85)
Adjusted operating profit - Continuing Operations
6
292
292
281
299
Net finance expense
6
(21)
(20)
(34)
(13)
Adjusted profit before tax - Continuing Operations
6
273
274
259
283
Adjusted Profit after Tax - Continuing Operations (pre excepts and amort)
6
207
207
199
216
Average diluted shares (m) (including impact of share buyback)
6
421.0
420.0
413.9
433.4
Adjusted diluted EPS (p) - continuing
6
49.2
48.7
47.2
51.7
Dividend/Share (p)
6
20.3
20.5
17.4
22.0
$/£ assumption (average rate)
5
1.28
1.28
1.28
1.30
€/£ assumption (average rate)
5
1.19
1.19
1.18
1.19

Disclaimer

Tate & Lyle PLC (“Tate & Lyle”) invites registered sell-side analysts that monitor Tate & Lyle’s stock to submit their forecasts to an external, web-based tool managed
by Vuma Financial Limited (“Vuma”), a company independent of Tate & Lyle.

The web-based tool generates an aggregation of publicly available forecasts collated exclusively by Vuma, but only on the basis of information submitted by those
analysts who choose to participate. The arithmetic average of the constituent analyst forecasts is known as “Consensus”. Vuma has no access to Tate & Lyle's
internal forecasts, budgets or any other information which is not publicly available.

Tate & Lyle has not commented on individual forecasts nor does it intend to do so in the future. Tate & Lyle assumes no obligation to update or revise such
information and nothing in this analysis should be taken as a recommendation to buy or sell shares in Tate & Lyle or to take any other action or place any reliance
on the analysis.

Consensus figures are provided for information only, and neither Tate & Lyle nor any of its subsidiary undertakings nor any director, officer or employee of
Tate & Lyle or any of its subsidiary undertakings accepts any responsibility for the accuracy or completeness of forecasts used in this analysis and therefore shall
have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in this analysis.